Concert Pharmaceuticals, Inc. will participate at the 28th Annual JP Morgan Healthcare Conference on Monday, January 11. The conference will take place at the Westin St. Francis Hotel in San Francisco, California. Speaking will be the company’s Chief Executive Officer Roger Tung, PhD.
Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.
The presentation will begin at 9:00 am PT that morning. Mr. Tung will provide a company overview during his discussion. Interested parties may listen to a webcast of the presentation online at http://www.concertpharma.com/. For more information, contact Justine Koenigsberg at 781.674.5284.
Concert Pharmaceuticals is a clinical stage biotechnology company focused on the application of deuterium chemistry to create novel and differentiated small molecule drugs. Concert’s approach leverages known activity and safety of existing drugs to reduce time, risk and expense of drug research and development. The Company has a broad research pipeline encompassing many therapeutic areas including infectious disease and renal disease, among others. In 2009, Concert entered into a potential $1 billion strategic alliance with GlaxoSmithKline to develop and commercialize certain deuterium-containing medicines. Founded in 2006, Concert has raised more than $110 million of venture and institutional capital.
Follow us on Twitter: http://www.twitter.com/pennystockspro
Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Us
Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
